Fabien Rebeaud

Title: Fabien Rebeaud: Innovator in Proteolytic Enzyme Research

Introduction

Fabien Rebeaud is a notable inventor based in Epalinges, Switzerland. He has made significant contributions to the field of proteolytic enzymes, particularly through his innovative research and patent work. His expertise and findings have implications for various applications in biochemistry and molecular biology.

Latest Patents

Fabien Rebeaud holds a patent titled "Malt1 specific cleavage in assay and screening method." This invention is based on the surprising discovery of a proteolytic cleavage function of human Malt1. The patent encompasses enzyme and screening assays, methods for assessing cleaving activity, and the use of Malt1 as a proteolytic enzyme. It also includes compounds comprising a peptide with specific amino acid sequences as substrates for proteolytic cleavage.

Career Highlights

Rebeaud is affiliated with the University of Lausanne, where he conducts his research. His work has garnered attention for its innovative approach to understanding enzyme functions and their applications in scientific research. His findings contribute to the broader understanding of proteolytic enzymes and their potential uses in various fields.

Collaborations

Fabien Rebeaud collaborates with esteemed colleagues, including Margot Thome and Stephan Hailfinger. These partnerships enhance the research environment and foster innovative ideas in the study of proteolytic enzymes.

Conclusion

Fabien Rebeaud's contributions to the field of proteolytic enzymes through his patent and research at the University of Lausanne highlight his role as an influential inventor. His work continues to pave the way for advancements in biochemical research and applications.